Centers of Excellence Designations, Clinical Outcomes, and Characteristics of Hospitals Performing Percutaneous Coronary Interventions

Documenti analoghi

• Use of Prasugrel and Ticagrelor in Stable Ischemic Heart Disease After Percutaneous Coronary Intervention, 2009–2016
  di: Dayoub, Elias J., et al.
  Pubblicazione: (2019)
• Variability in Reported Percutaneous Coronary Intervention Mortality Among Physicians Practicing at Multiple Sites in New York State
  di: Yang, Nancy, et al.
  Pubblicazione: (2020)
• Association Between 30-Day Mortality After Percutaneous Coronary Intervention and Education and Certification Variables for New York State Interventional Cardiologists
  di: Khatana, Sameed Ahmed M., et al.
  Pubblicazione: (2018)
• Federal Payments for Coronary Revascularization Procedures Among Dual Enrollees in Medicare Advantage and the Veterans Affairs Health Care System
  di: Dayoub, Elias J., et al.
  Pubblicazione: (2020)
• Adoption of PCSK9 Inhibitors Among Patients With Atherosclerotic Disease
  di: Dayoub, Elias J., et al.
  Pubblicazione: (2021)